19 May 2013
Keywords: amarin, licenses, nasal, lorazepam, elan, london, uk-based
Article | 12 March 2007
London, UK-based Amarin Corp has acquired a global license to develop and market Irish drugmaker Elan's novel, nasal lorazepam formulation ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 February 2007
17 May 2013
© 2013 thepharmaletter.com